Dr. Eric D Kater, MD Radiology - Body Imaging Medicare: Accepting Medicare Assignments Practice Location: 3600 E Harry St, Wichita, KS 67218 Phone: 316-689-5050 |
Dr. Kamran M Ali, MD Radiology - Diagnostic Radiology Medicare: Accepting Medicare Assignments Practice Location: 551 N Hillside St, Suite 320, Wichita, KS 67214 Phone: 316-685-1367 |
Joyce A Oster, MD Radiology - Diagnostic Radiology Medicare: Not Enrolled in Medicare Practice Location: 3600 E Harry St, Wichita, KS 67218 Phone: 316-689-5050 Fax: 316-689-6192 |
Dr. Thomas J Flynn, MD Radiology - Diagnostic Radiology Medicare: Accepting Medicare Assignments Practice Location: 929 N Saint Francis St, Wichita, KS 67214 Phone: 316-268-5000 |
Dr. Christopher G Baalmann, M.D. Radiology - Diagnostic Radiology Medicare: Accepting Medicare Assignments Practice Location: 9300 E 29th St N Ste 206, Wichita, KS 67226 Phone: 316-260-6763 |
News Archive
Jubilant Organosys, the University of Alabama at Birmingham (UAB), and Southern Research Institute today announced a joint venture that will focus on leveraging their collective innovation and enabling technologies in the areas of Oncology, Metabolic Disease and Infectious Diseases. It is a unique U.S.-India arbitraged and leveraged partnership that will accelerate the development of affordable therapies for patients worldwide.
As Congress debates cutting prescription drug costs, a poll released Tuesday found the vast majority of adults — regardless of their political party or age — support letting the federal government negotiate drug prices for Medicare beneficiaries and those in private health insurance plans.
Royal Philips, a leader in health technology, today announced the launch of a proof-of-concept pilot for digital pathology services at a large, multi-region, scale. Announced at ehi Live, the pilot will last up to 12 months and is designed to establish ease-of-adoption for a fully integrated and digitised national pathology service, across Scottish NHS providers.
New research published in The Lancet has shown that a drug, currently used in the treatment of Type II diabetes, can be effective in clearing fatty liver disease from some patients.
› Verified 3 days ago